Alaunos Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Groenewald Ferdinand
Feb 28 21:49 ET
Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Discovery Capital Management, LLC(1.66%),Robert K. Citrone(1.66%), etc.
Feb 14 12:49 ET
Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MSD Partners, L.P.(9.2%),MSD Credit Opportunity Master Fund, L.P.(9.2%), etc.
Feb 13 18:21 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hogue Dale Curtis Jr.
Jan 23 00:00 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hogue Dale Curtis Jr.
Jan 3 00:00 ET
Alaunos Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hogue Dale Curtis Jr.
Jan 3 00:00 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Boyle Kevin S. Sr.
Sep 5, 2023 17:34 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Postma Robert W
Jun 8, 2023 17:27 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hofmeister Robert
Jun 8, 2023 17:24 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thistle Mary
Jun 8, 2023 17:23 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Huang James
Jun 8, 2023 17:22 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Vieser Jaime
Jun 8, 2023 17:17 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Weis Holger
Jun 8, 2023 17:10 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hofmeister Robert
Apr 19, 2023 17:00 ET
Alaunos Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hofmeister Robert
Apr 19, 2023 16:30 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Srivastava Abhishek K
Mar 17, 2023 20:30 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wong Michael
Mar 17, 2023 20:30 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Boyle Kevin S. Sr.
Mar 17, 2023 20:30 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Deniger Drew
Mar 17, 2023 20:30 ET
Alaunos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lackey Melinda
Mar 17, 2023 20:30 ET
No Data
No Data